Becton, Dickinson and Company company logo

# 1st Gen Model Becton, Dickinson and Company Surgical & medical instruments

77.36% successful of 53 deals
$211.83 Last close price
at 20-oct-2017


Model's trade recommendations 0.55% Return for period

8.53% Annual return

$47.27B Market Cap

β 1.05  


Model (following trade recommendations)


Underlying stock

S&P 500

Return for period 0.55%
52wk return 6.64%
52wk Range
Sortino ratio 1.74
Sharpe ratio 1.23
Norm. RMSE 0.30%
Downside risk 4.65%
Volatility 6.59%
  • 2.92 (1.41%) Div (Yield)
  • STRONG BUY Analysts consensus recommendation

Becton, Dickinson and Co. is engaged principally in the manufacture and sale of a broad line of supplies, devices and systems used by health care professionals, medical research institutions and the general public. BD's operations consist of three worldwide business segments: Medical Systems, Biosciences, and Preanalytical Solutions.

Industry sector: Medical

Sector classification: Surgical & medical instruments

Deep Learning based analysis and prediction model for Becton, Dickinson and Company (BDX) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Oct. 2, 2015.

Market data for BDX model training are being downloaded from the Quandl premium datasets on a daily basis.

Model is being retrained on a daily basis.

Float 224M
P/E 22.55
Shares Outstanding 228M
% Held by Insiders 1.40%
% Held by Institutions 87.12%
EPS (last reported FY) $8.59
EPS (last reported Q) $2.46
EPS, estimated (last reported Q) $2.44
Total revenues $12 B
Net income $1 B